Dietary Reporting in the Amyloidoses
- Conditions
- Amyloidosis
- Interventions
- Other: Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)
- Registration Number
- NCT05738005
- Lead Sponsor
- Barbara Ann Karmanos Cancer Institute
- Brief Summary
The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis.
The main question it aims to answer is:
Is it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amyloidosis patients
Participants will be asked to:
* Download the MyFitnessPal application on their smartphone and view an online tutorial
* After a week of practice, from weeks 2-9, participants will enter daily dietary intake as well as daily herbal/alternative supplement intake into the MyFitnessPal application on their smartphone.
* complete a questionnaire prior to starting the application, after week 2 and at week 10 after starting the application
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 40
- 18 years of age or older
- Diagnosed with any type of amyloidosis
- Speak, read and write in English
- Willing to use the MyFitnessPal app on their own smartphone
- a planned autologous stem cell transplant or a solid organ transplant in the 12 weeks after enrollment
- cognitive or perceptual disturbances
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app) Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app) MyFitnessPal smartphone application is used to track daily dietary intake and herbal/alternative supplements.
- Primary Outcome Measures
Name Time Method Adherence Rate 56 days The adherence is defined by the status (yes vs. no) of data recording per day; The adherence rate will be calculated by the ratio of the number of days of adherence to the total number of days of trial (i.e., 56 days); The status of data recording per day will be considered 'yes' if the participant completes a daily survey.
- Secondary Outcome Measures
Name Time Method Subsequent adherence rate 63 days (= 56 days + Week 10) The subsequent adherence is the status of data recording per day during the third phase (Week 10) of trial participation (i.e., 7 days); The subsequent adherence rate will be calculated by the ratio of the number of days of adherence during the third phase (Week 10) of trial participation (i.e., 7 days); The status of data recording per day will be considered 'yes' if the participant completes a daily survey.
Trial Locations
- Locations (1)
Karmanos Cancer Institute
🇺🇸Detroit, Michigan, United States